Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 106

Similar articles for PubMed (Select 22174561)

1.

Antitumor activity of artemisinin and its derivatives: from a well-known antimalarial agent to a potential anticancer drug.

Crespo-Ortiz MP, Wei MQ.

J Biomed Biotechnol. 2012;2012:247597. doi: 10.1155/2012/247597. Epub 2011 Nov 22. Review.

2.

Synthesis of a novel series of fluoroarene derivatives of artemisinin as potent antifungal and anticancer agent.

Buragohain P, Surineni N, Barua NC, Bhuyan PD, Boruah P, Borah JC, Laisharm S, Moirangthem DS.

Bioorg Med Chem Lett. 2015 May 30. pii: S0960-894X(15)00541-7. doi: 10.1016/j.bmcl.2015.05.067. [Epub ahead of print]

PMID:
26099535
3.

Anti-inflammatory and immunoregulatory functions of artemisinin and its derivatives.

Shi C, Li H, Yang Y, Hou L.

Mediators Inflamm. 2015;2015:435713. doi: 10.1155/2015/435713. Epub 2015 Apr 16. Review.

4.

Anticancer Effect of AntiMalarial Artemisinin Compounds.

Das AK.

Ann Med Health Sci Res. 2015 Mar-Apr;5(2):93-102. doi: 10.4103/2141-9248.153609. Review.

5.

New use for old drugs? Prospective targets of chloroquines in cancer therapy.

Vlahopoulos S, Critselis E, Voutsas IF, Perez SA, Moschovi M, Baxevanis CN, Chrousos GP.

Curr Drug Targets. 2014;15(9):843-51. Review.

PMID:
25023646
6.

Artemisinin and curcumin inhibit Drosophila brain tumor, prolong life span, and restore locomotor activity.

Das SS, Nanda GG, Alone DP.

IUBMB Life. 2014 Jul;66(7):496-506. doi: 10.1002/iub.1284. Epub 2014 Jun 27.

PMID:
24975030
7.

Development of anticancer drugs based on the hallmarks of tumor cells.

Bailón-Moscoso N, Romero-Benavides JC, Ostrosky-Wegman P.

Tumour Biol. 2014 May;35(5):3981-95. doi: 10.1007/s13277-014-1649-y. Epub 2014 Jan 29. Review.

PMID:
24470139
8.

[The role and mechanism of anticancer of dihydroartemisinin].

Jia L, Li X.

Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2013 Sep;27(18):1033-6. Review. Chinese.

PMID:
24459940
9.

Anticancer properties of distinct antimalarial drug classes.

Hooft van Huijsduijnen R, Guy RK, Chibale K, Haynes RK, Peitz I, Kelter G, Phillips MA, Vennerstrom JL, Yuthavong Y, Wells TN.

PLoS One. 2013 Dec 31;8(12):e82962. doi: 10.1371/journal.pone.0082962. eCollection 2013.

10.

Artemisinin rewires the protein interaction network in cancer cells: network analysis, pathway identification, and target prediction.

Huang C, Ba Q, Yue Q, Li J, Li J, Chu R, Wang H.

Mol Biosyst. 2013 Dec;9(12):3091-100. doi: 10.1039/c3mb70342h. Epub 2013 Oct 2.

PMID:
24085322
11.

[Research advance in antitumor activities of artemisinin and its derivatives].

Yang H, Tan XJ.

Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2013 Aug;35(4):466-71. doi: 10.3881/j.issn.1000-503X.2013.04.021. Review. Chinese.

12.

New approaches in antimalarial drug discovery and development: a review.

Aguiar AC, Rocha EM, Souza NB, França TC, Krettli AU.

Mem Inst Oswaldo Cruz. 2012 Nov;107(7):831-45. Review.

13.

Antimalarial and anticancer activities of artemisinin-quinoline hybrid-dimers and pharmacokinetic properties in mice.

Lombard MC, N'Da DD, Breytenbach JC, Kolesnikova NI, Tran Van Ba C, Wein S, Norman J, Denti P, Vial H, Wiesner L.

Eur J Pharm Sci. 2012 Dec 18;47(5):834-41. doi: 10.1016/j.ejps.2012.09.019. Epub 2012 Oct 13.

PMID:
23069618
14.

Development of artemisinin compounds for cancer treatment.

Lai HC, Singh NP, Sasaki T.

Invest New Drugs. 2013 Feb;31(1):230-46. doi: 10.1007/s10637-012-9873-z. Epub 2012 Aug 31. Review.

PMID:
22935909
15.
16.

Translational research in oncology: the need of additional in vitro preclinical testing methods for new drugs.

Drell TL 4th, Zanker KS, Entschladen F.

Curr Pharm Des. 2012;18(23):3416-20. Review.

PMID:
22663553
17.

Discovery of anticancer drugs from antimalarial natural products: a MEDLINE literature review.

Duffy R, Wade C, Chang R.

Drug Discov Today. 2012 Sep;17(17-18):942-53. doi: 10.1016/j.drudis.2012.03.013. Epub 2012 Apr 1. Review.

PMID:
22504324
18.

Antiproliferative effects of artemisinin on human breast cancer cells requires the downregulated expression of the E2F1 transcription factor and loss of E2F1-target cell cycle genes.

Tin AS, Sundar SN, Tran KQ, Park AH, Poindexter KM, Firestone GL.

Anticancer Drugs. 2012 Apr;23(4):370-9. doi: 10.1097/CAD.0b013e32834f6ea8.

PMID:
22185819
19.

Cytotoxic/tumor suppressor role of zinc for the treatment of cancer: an enigma and an opportunity.

Costello LC, Franklin RB.

Expert Rev Anticancer Ther. 2012 Jan;12(1):121-8. doi: 10.1586/era.11.190. Review.

20.

Discovery of artemisinin-glycolipid hybrids as anti-oral cancer agents.

Ricci J, Kim M, Chung WY, Park KK, Jung M.

Chem Pharm Bull (Tokyo). 2011;59(12):1471-5.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk